No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ALC240719P90000
- 1.85
- +0.15+8.82%
15min DelayClose Jun 28 16:00 ET
1.90High1.85Low
1.85Open1.70Pre Close12 Volume202 Open Interest90.00Strike Price2.23KTurnover18.71%IV1.04%PremiumJul 19, 2024Expiry Date0.92Intrinsic Value100Multiplier19DDays to Expiry0.93Extrinsic Value100Contract SizeAmericanOptions Type-0.5674Delta0.1051Gamma46.28Leverage Ratio-0.0329Theta-0.0222Rho-26.25Eff Leverage0.0807Vega
Intraday
- 5D
- Daily
News
Calculating The Fair Value Of Alcon Inc. (VTX:ALC)
BTIG Maintains Alcon(ALC.US) With Buy Rating, Maintains Target Price $92
BTIG analyst Ryan Zimmerman maintains $Alcon(ALC.US)$ with a buy rating, and maintains the target price at $92.According to TipRanks data, the analyst has a success rate of 46.3% and a total average r
Are Options Traders Betting on a Big Move in Alcon (ALC) Stock?
Alcon Says Unity Vitreoretinal Cataract, Cataract Systems Get FDA Clearance
Alcon (ALC) said Monday its Unity vitreoretinal cataract system and Unity cataract system have received the US Food and Drug Administration's 510(k) clearance. The company said it tested the systems d
Wells Fargo Maintains Alcon(ALC.US) With Buy Rating, Announces Target Price $94
Wells Fargo analyst Larry Biegelsen maintains $Alcon(ALC.US)$ with a buy rating, and sets the target price at $94.According to TipRanks data, the analyst has a success rate of 59.3% and a total averag
Alcon Receives FDA Clearance for Revolutionary Cataract and Vitreoretinal Systems
Alcon (NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS) have received
Comments
$Alcon(ALC.US$ we broke out of that weekly resistance 89.43, lets see if we can continue to 90.66/90.94
$Alcon(ALC.US$
interesting setup. if we are able to break 89.43, we could see 90.66 / 90.44 and 91.88+. Reject 89.43 could take this down to 88.21 / 88.49 and maybe 86.98
interesting setup. if we are able to break 89.43, we could see 90.66 / 90.44 and 91.88+. Reject 89.43 could take this down to 88.21 / 88.49 and maybe 86.98
5
Baird advocates medtech companies such as Alcon, Stryker, and Cooper due to product and pricing strengths. Belief is strong in Alcon's 2024 margin possibilities, Stryker's premium pricing and predicted robust orthopedic demand, and projected revenue growth for Boston Scientific and Axonics.
Gapping up
$Rivian Automotive(RIVN.US$ +6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.)
$Celsius Holdings(CELH.US$ +11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...
$Rivian Automotive(RIVN.US$ +6% (The company reported a first-quarter loss that was narrower than expected. Rivian also said it's still on track to meet a 50,000-vehicle production target for 2023.)
$Celsius Holdings(CELH.US$ +11.1% (The company posted a strong earnings report. Celsius posted 40 cents in earnings per share for the first quarter, more than doubling the 19-cent consensus estimate of analysts polled by Str...
11
Read more
103480872 : congrats
sentosa island : Alco is good